GlassScriptPhysician profile
Jenna Mcconnell
NPI 1306450176
$15,202.85
in general payments reported to CMS, 2019-2025
39 companies · $3,287 in 2025
The $3,287 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.00 · 2022: $3,291 · 2023: $5,284 · 2024: $3,328 · 2025: $3,287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $1,396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,502.56 |
| Travel and Lodging | $1,396.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,503.53 | 2022-2025 | Minimed 780g, Minimed 770g |
| Novo Nordisk INC | $1,634.11 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $1,538.47 | 2022-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $947.80 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $912.71 | 2022-2025 | |
| Amgen INC. | $842.31 | 2022-2025 | Evenity, Prolia, Repatha |
| Abbott Laboratories | $833.26 | 2022-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $812.82 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $781.45 | 2022-2025 | |
| Beta Bionics, INC. | $627.42 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Boehringer Ingelheim Pharmaceuticals, INC. | $553.11 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Xeris Pharmaceuticals, INC. | $492.35 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Corcept Therapeutics | $472.96 | 2022-2025 | Korlym |
| Aimmune Therapeutics, INC. | $244.54 | 2024-2025 | Zenpep, Vowst |
| Exact Sciences Corporation | $207.68 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $181.08 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Mannkind Corporation | $173.58 | 2022-2025 | Afrezza |
| Esperion Therapeutics, INC. | $156.75 | 2022-2025 | Nexletol |
| Amarin Pharma, INC. | $151.46 | 2022 | |
| Merck Sharp & Dohme LLC | $131.00 | 2022-2023 | Steglatro, Belsomra, Verquvo |
| Insulet Corporation | $119.99 | 2023-2024 | Omnipod |
| Intuity Medical INC | $97.65 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Antares Pharma, INC. | $84.91 | 2022-2023 | Nocdurna, Xyosted, Tlando |
| Cequr Corporation | $80.38 | 2022-2025 | Cequr Simplicity |
| Pfizer INC. | $73.28 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $73.04 | 2022-2024 | Xarelto |
| Amneal Pharmaceuticals LLC | $71.01 | 2023-2024 | Unithroid |
| Daiichi Sankyo INC. | $70.65 | 2022-2023 | Injectafer |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.32 | 2022-2023 | Cycloset |
| Zealand Pharma US, INC. | $51.10 | 2022 | |
| Halozyme INC | $40.21 | 2023 | |
| Nestle Healthcare Nutrition INC. | $34.73 | 2023 | |
| Ucb, INC. | $32.92 | 2022 | |
| Amphastar Pharmaceuticals, INC. | $31.80 | 2023 | Baqsimi |
| Sanofi-Aventis U.S. LLC | $28.68 | 2023 | |
| Tolmar, INC. | $15.84 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.12 | 2022 | |
| Amryt Pharma Holdings LTD | $13.05 | 2023 | Mycapssa |
| Grt US Holding, INC. | $10.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Mcconnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.